Flaxseed on insulin resistance in ulcerative colitis
- Conditions
- Men and women aged 55-18 years with ulcerative colitis (mild to moderate).Ulcerative colitis
- Registration Number
- IRCT20201229049878N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 64
Age 18 to 55 years
Body Mass Index (BMI) 18.5 and above
Histopathologically confirmed ulcerative colitis
The duration of ulcerative colitis should be at least 3 months.
No change in the type and dose of medication used during the last 3 months
Patients are in the active stage (mild to moderate) of the disease.
Willingness to cooperate in this project
Other intestinal diseases and disorders, autoimmune diseases, cancer, inflammatory and infectious diseases
Diabetes or hyperlipidemia (taking drugs that stimulate insulin secretion (such as glibenclamide) or drugs that affect lipid profile (such as statins))
History of gastrointestinal surgery
Having other gastrointestinal diseases or gastrointestinal surgery during the study
Pregnancy and lactation
Use of anti-TNF alpha or immunomodulatory drugs (methotrexate and prednisolone) at or during the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method